1 / 76

3D Structures of Biological Macromolecules Part 3: Drug Research and Design

3D Structures of Biological Macromolecules Part 3: Drug Research and Design. Jürgen Sühnel jsuehnel@fli-leibniz.de. Leibniz Institute for Age Research, Fritz Lipmann Institute, Jena Centre for Bioinformatics Jena / Germany. Supplementary Material: www.fli-leibniz.de/www_bioc/3D/.

paul
Download Presentation

3D Structures of Biological Macromolecules Part 3: Drug Research and Design

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. 3D Structures of Biological Macromolecules Part 3: Drug Research and Design Jürgen Sühnel jsuehnel@fli-leibniz.de Leibniz Institute for Age Research, Fritz Lipmann Institute, Jena Centre for Bioinformatics Jena / Germany Supplementary Material: www.fli-leibniz.de/www_bioc/3D/

  2. Example of Drug Discovery

  3. Example of Drug Discovery

  4. Example of Drug Discovery Pacific yew tree (Eibe)

  5. Drug Research is the Search for a Needle in a Haystack. www.kubinyi.de

  6. Development of Drug Research www.kubinyi.de

  7. Drug Timeline www.kubinyi.de

  8. Drug Timeline www.kubinyi.de

  9. Costs in Drug Research • Cost for discovering and developing a new drug:several € 100 million up to € 1000 million (average € 802 M) • Time to market: 10 – 15 years

  10. Pharma Sales and Earnings in 1999 - 2002 ww.kubinyi.de

  11. The World’s Top-Selling Drugs in 2004

  12. Disciplines Involved in Drug Development Molecular Conceptor

  13. The Role of Molecular Structure Molecular Conceptor

  14. The Pharmacophore Concept Molecular Conceptor

  15. Mechanisms of Drug Action – Definitions I www.kubinyi.de

  16. Mechanisms of Drug Action – Definitions II www.kubinyi.de

  17. Serendipity - Penicillin Molecular Conceptor

  18. Serendipity - Aspirin Serendipity - Aspirin Molecular Conceptor

  19. Strategies in Drug Design www.kubinyi.de

  20. Computational Approaches to Drug Research • Target identification • Lead discovery • Lead optimization • Ligand-based design • Receptor-based design (Docking) • Database screening (Virtual screening) • Supporting combinatorial chemistry

  21. 3D Structures in Drug Design www.kubinyi.de

  22. Lead Structure Identification www.kubinyi.de

  23. Lead Structure Search Pipeline www.kubinyi.de

  24. Lead Structures: Endogenous Neurotransmitters voluntary www.kubinyi.de

  25. Lead Structures: Endogenous Neurotransmitters Neurotransmitters are chemicals that are used to relay, amplify and modulate electrical signals between a neuron and another cell. Acetylcholine: voluntary movement of the muscles Noradrenaline: wakefulness or arousal Dopamine: voluntary movement and emotional arousal Serotonin: sleep and temperature regulation GABA: (gamma aminobutryic acid) - motor behaviour www.kubinyi.de

  26. Lead Optimization www.kubinyi.de

  27. Ligand-based Design: What is QSAR ?

  28. Ligand-based Design:Basic Requirements for QSAR Studies

  29. Ligand-based Design: QSAR Hansch analysis is the investigation of the quantitative relationship between the biological activity of a series of compounds and their physicochemical substituent or global parameters representing hydrophobic, electronic, steric and other effects using multiple regression correlation methodology. www.kubinyi.de

  30. Ligand-based Design: QSAR Parameters www.kubinyi.de

  31. Ligand-based Design: QSAR Parameters

  32. Ligand-based Design: QSAR Parameters - Lipophilicity

  33. Ligand-based Design: QSAR Parameters www.kubinyi.de

  34. Ligand-based Design: QSAR Parameters www.kubinyi.de

  35. Ligand-based Design: QSAR Parameters www.kubinyi.de

  36. Ligand-based Design: QSAR Parameters www.kubinyi.de

  37. Ligand-based Design: QSAR Parameters www.kubinyi.de

  38. Ligand-based Design: QSAR Parameters www.kubinyi.de

  39. Ligand-based Design: A QSAR Success Story www.kubinyi.de

  40. Ligand-based Design: A QSAR Success Story pI50 – concentration of test compound required to reduce the protein content of cell by 50% www.kubinyi.de

  41. Ligand-based Design: 3D-QSAR CoMFA www.kubinyi.de

  42. Molecular Superposition of D Receptor Ligands www.kubinyi.de

  43. Ligand-based Design: 3D-QSAR CoMFA www.kubinyi.de

  44. Ligand-based Design: 3D-QSAR CoMFA www.kubinyi.de

  45. Electrostatic and Van-der-Waals Interactions

  46. Ligand-based Design: 3D-QSAR CoMFA Comparative Molecular Field Analysis

  47. Receptor-based Design (Structure-based Design) Molecular Conceptor

  48. Receptor-based Design (Structure-based Design) Molecular Conceptor

  49. Receptor-based Design: Docking Molecular Conceptor

  50. Receptor-based Design: Docking Molecular Conceptor

More Related